The quantitative analysis of epigenetics for tailor-made cancer therapy
Project/Area Number |
20791516
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Surgical dentistry
|
Research Institution | Okayama University |
Principal Investigator |
MATSUZAKI Hidenobu Okayama University, 岡山大学病院, 助教 (70325124)
|
Project Period (FY) |
2008 – 2009
|
Project Status |
Completed (Fiscal Year 2009)
|
Budget Amount *help |
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2009: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 実験腫瘍学 / 臨床 / 薬理 / 遺伝子 / 発現制御 |
Research Abstract |
In the present study, we examined the effects of FR901228, a histone deacetylase (HDAC) inhibitor, on epigenetic regulation of gene expression in oral cancer cell lines. The epigenetic status was quantified before and after FR901228 treatment via chromatin immuno-precipitation assay (ChIP). The methylation status was also quantitatively examined after 5-aza-dC/ FR901228 treatment. Moreover, the alterd-expression of genes related to angiogenesis and invasion may contribute to the recuperation of biological functions linked to FR901228 such as an inhibitory effect on tumor angiogenesis and cell invasion. These results indicate that FR901228 and its target genes may be excellent leads for future studies on the potential benefits of HDAC inhibitors and epigenetics in cancer therapy.
|
Report
(3 results)
Research Products
(9 results)
-
[Journal Article] A new phantom using polyethylene glycol as an apparent diffusion coefficient standard for MR imaging2009
Author(s)
atsuya R, Kuroda M, Matsumoto Y, Kato H, Matsuzaki H, Asaumi J, Murakami JKatashima K, Ashida M, Sasaki T, Sei T, Himei K, Katsui K, Katayama N, Takemoto M, Kanazawa S, Mimura S, Oono S, Kitayama T, Tahara S, Inamura K
-
Journal Title
Int J Oncol ol.35、No.4
Pages: 893-900
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-